Why Is RAYMOND JAMES FINL I (RJF) Stock Down Today?

Raymond James Financial (RJF) stock fell 5.09% to $156.79 in early trading on Friday, marking a sharp decline from its opening price of $165.00. The drop came amid mixed analyst activity and recent insider selling, with the stock now down 8.9% over the past eight sessions. The intraday low of $156.53 was reached at 10:25 AM ET, as volume so far amounted to 0.3 million shares, or 0.2 times the 3-month daily average.

What Happened

Raymond James has been active on the analyst front, with several recent upgrades and reiterations across various sectors. The firm raised Meridian Mining’s price target to C$3 and reiterated a Strong Buy rating on Lexeo and Tonix Pharma. It also maintained a Strong Buy on Verizon and Lennar, citing subscriber growth and mortgage rate dynamics. Raymond James also named three top industrial stocks in a new favorites list and raised Orezone Gold’s price target after a mine visit. However, these positive analyst actions did not translate into investor confidence in the firm’s own stock.

Recent insider transactions have drawn attention, with three executives selling shares totaling $4.1 million in the past 90 days. The most recent sale occurred on August 28 by Chief Administrative Officer Allaire Bella Loykhter. Additionally, former President Elwyn Tashtego S and Executive Chair Raney Steven M also sold shares earlier in the summer.

What The Data Shows

The stock is currently trading within its 52-week range of $138.82 to $182.73 and has printed 27 fresh 52-week lows on September 22. The company has a market cap of $31.7 billion, with a P/E ratio of 14.4 and a revenue growth of 10.7% in the trailing twelve months. Despite a 15.1% net margin and a 1.31% dividend yield, the stock’s beta of 0.92 suggests it is slightly less volatile than the broader market.

What To Watch

Investors should monitor Raymond James’ Q3 2026 earnings call, scheduled for later this month. The stock is also under coverage from several firms, including Truist Securities, which recently initiated a Hold rating with a $188 price target, and TD Cowen, which lowered its target to $160.